Integrative Parkinson's Care That Looks Beyond the Diagnosis
A personalized evaluation of movement, sleep, gut, cognition, and the upstream drivers no standard visit addresses.
Book Your ConsultationYou or someone close to you received a Parkinsonism diagnosis, or a neurologist used the word without fully explaining what it means. You know something is changing: the walk is slower, the handwriting smaller, sleep is disrupted, and energy is not what it was. What you do not know is why, or what to do about it beyond the prescription handed over at the end of the appointment.
At Mind Body Neurology, we start with the question most neurology visits skip: what is driving this, and what else is making it worse? Parkinsonism is not a single disease. It is a symptom pattern with multiple causes and multiple modifiable contributors. Getting the right answer on both questions changes the plan entirely.
Dr. Alexander Y. Zubkov, MD, PhD sees patients in person in Minnesota and via telehealth in Mississippi, Florida, Georgia, Arkansas, and Tennessee.
On This Page
What Is Parkinsonism?
Parkinsonism describes a cluster of movement changes: slowness (bradykinesia), muscular stiffness, a tremor at rest, and postural instability. Parkinson's disease is the most common cause, but it is one of several. Medications, particularly antipsychotics and some anti-nausea drugs, are a common and reversible cause that goes unrecognized far too often. Vascular changes in the brain, prior head injuries, toxin exposures, and atypical neurodegenerative syndromes such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA) all produce the same outward picture.1
The distinction matters because prognosis and treatment differ substantially across causes. A patient whose parkinsonism is medication-induced and reversible should not be on a Parkinson's medication for years. A patient with atypical parkinsonism needs to know early because the disease course and mobility risks are different. Sorting out the diagnosis is the first priority, and a thorough neurologic evaluation is what accomplishes this.
Parkinson's disease itself involves the progressive loss of dopamine-producing neurons in the substantia nigra. Less widely known is the fact the disease process starts far earlier, often a decade or more before motor symptoms appear, in the brainstem and in the gut's enteric nervous system.2 This early period, when the disease is building below the level of movement, is where lifestyle and targeted intervention carry the most weight.
Parkinsonism often shows up as:
- Slowness of movement. Tasks once automatic now take longer and more effort
- Stiffness in the arms, neck, or shoulders, especially in the morning
- A resting tremor in one hand or arm that settles with movement
- Smaller steps, reduced arm swing, or shuffling gait
- Loss of sense of smell, often years before any movement change
- Vivid dreams with physical movement during sleep (REM sleep behavior disorder)
- Constipation or slow gut motility, a non-motor symptom preceding motor symptoms by years in many cases
- Soft voice, smaller handwriting, reduced facial expression
- Lightheadedness on standing, fatigue, brain fog, anxiety, or depression
The non-motor symptoms, particularly loss of smell, REM sleep behavior disorder, and constipation, are among the earliest markers of the disease process. They belong in every evaluation, not only the ones starting with a fall or a tremor.
An Integrative Neurology Approach to Parkinsonism
Standard neurology does important work: it confirms the diagnosis, rules out reversible causes, and manages symptoms with medication. Our role is to build the plan alongside this work, focused on what you do every day, what your body is missing, and what is accelerating the process.
Neurologic Evaluation and Diagnosis Clarity
Detailed history, movement exam, medication review, and prior imaging review. We confirm or clarify the diagnosis and rule out reversible causes before building any plan.
Targeted Lab and Functional Testing
Screening for nutrient gaps (B12, vitamin D, CoQ10 precursors), inflammatory markers, thyroid, metabolic function, gut barrier markers, and environmental exposures where indicated.
Personalized Integrative Plan
A stepwise plan covering exercise prescription, sleep architecture, gut health, nutrition, stress load, relevant supplements, and coordination with your movement disorder neurologist.
Upstream Drivers Affecting Parkinson's Trajectory
Dopamine replacement addresses the symptom. It does not address the conditions accelerating the underlying process. When we evaluate someone with Parkinsonism, we look for the drivers and amplifiers within reach.
Sleep and REM Behavior Disorder
Sleep disruption in Parkinsonism is both a symptom and an accelerant. Poor sleep worsens motor function, cognition, mood, and energy, and over time chronic sleep fragmentation promotes the neuroinflammation accelerating neurodegeneration. REM sleep behavior disorder, in which the normal muscle paralysis of REM sleep fails and people physically act out their dreams, is one of the most specific early markers of Parkinson's disease and related syndromes. Identifying it, treating it, and protecting sleep architecture is a clinical priority, not an afterthought.3
Gut Health and the Gut-Brain Axis
The research on gut-brain connection in Parkinson's disease is among the most important in neurology right now. Alpha-synuclein, the protein aggregating in Parkinson's disease, appears to originate in the enteric nervous system and travel upward through the vagus nerve, reaching the brainstem years before motor symptoms emerge.2 Constipation, affecting a large percentage of people with Parkinson's disease and often preceding diagnosis by years, is not a side effect of the disease. It is a core feature. Addressing gut motility, microbiome health, and gut barrier integrity belongs in the integrative plan.
Insulin Resistance and Metabolic Health
Insulin resistance impairs mitochondrial function in neurons, reduces the brain's ability to use glucose for energy, and drives neuroinflammation, three mechanisms directly relevant to Parkinson's disease pathology.4 Measuring and addressing metabolic health is part of every evaluation, including fasting glucose, insulin, HbA1c, and a practical look at dietary patterns and body composition.
Environmental Toxin Exposure
Pesticide exposure, particularly organophosphates, paraquat, and rotenone, is among the most consistently replicated environmental risk factors for Parkinson's disease in the epidemiological literature.5 Research also links heavy metal exposure, chronic solvent exposure, and well water contamination to elevated risk. We take a thorough exposure history and, where indicated, use targeted testing to identify ongoing burden a standard neurology visit never asks about.
Nutrient Gaps and Mitochondrial Support
Mitochondrial dysfunction sits at the center of the neurodegeneration in Parkinson's disease. Parkinson's disease depletes many of the nutrients supporting mitochondrial health, including coenzyme Q10, B vitamins, NAD+ precursors, and glutathione precursors. Vitamin D deficiency is more prevalent in people with Parkinson's disease than in the general population. Studies point to urate and creatine as neuroprotective in this context. We do not prescribe a generic supplement protocol. We test, identify what is depleted, and build from there.
Sleep, gut health, metabolic function, toxic burden, physical conditioning, and nutrient status all shape how Parkinson's progresses day to day. These are not small variables. They are where your leverage lives, and a standard 20-minute appointment does not have room for any of them. This is what we are here for.
Book Your ConsultationExercise Is a Treatment, Not a Suggestion
The evidence for exercise in Parkinson's disease is stronger than for most supplements and comparable to some medications. High-intensity aerobic exercise, boxing programs designed for Parkinson's, tango and rhythmic movement training, and forced-rate cycling on stationary bikes have all shown measurable benefit in peer-reviewed clinical trials, reducing motor symptom severity, improving balance, and in some studies slowing disease progression.3
This is not about staying active in a general sense. It is about structured, progressive, high-effort physical activity targeted to the specific deficits of Parkinsonism: balance, gait, rotational movement, dual-task coordination, and forced-amplitude training. We help you identify the right program type for your current function level and build it into your plan with the same clinical seriousness as any other treatment we prescribe.
Find the Foods Driving Neuroinflammation
Systemic inflammation is a key accelerant in Parkinson's disease, and food reactivity is one of the most overlooked contributors to inflammatory load. Oxford MRT is a blood test measuring how your immune system responds to over 170 foods and food chemicals, identifying the specific items driving immune activation in your body. For patients managing a progressive neurologic condition, removing the inputs constantly restimulating inflammation is a practical and targeted strategy. Instead of guessing, MRT gives you a precise list.
Get the MRT Food Sensitivity TestIs This the Right Fit for You?
Good fit:
- You have a Parkinsonism or Parkinson's disease diagnosis and want to address it more comprehensively than a standard neurology visit allows
- You want help connecting the dots between symptoms (the constipation, the sleep disruption, the fatigue) and the underlying disease process
- You are managing Parkinson's alongside another condition and want someone who sees the whole picture
- Your family member has Parkinsonism and you want guidance on supporting their function and slowing progression
- You want a second opinion on a parkinsonism diagnosis before committing to long-term medication
- You are in Minnesota, Mississippi, Florida, Georgia, Arkansas, or Tennessee and need telehealth access to this level of care
Not the right fit:
- You need urgent medication adjustment for off-period management or severe motor fluctuations. Your movement disorder neurologist handles this, not an integrative visit.
- You are in rapid functional decline and need immediate subspecialty care. Go to the emergency room or contact your neurologist directly.
- You are looking for a provider to replace your current neurologist rather than work alongside them.
- You are seeking a provider whose primary role is prescribing Parkinson's medications. Medication management for Parkinson's disease is a movement disorder specialty function.
Frequently Asked Questions
Still have questions? Book a consultation and get answers specific to your case.
Parkinson's disease is the most common cause of parkinsonism, the symptom pattern of slowness, stiffness, and tremor. Other causes include certain medications, vascular changes in the brain, head trauma, toxin exposures, and atypical neurodegenerative syndromes such as progressive supranuclear palsy (PSP) or multiple system atrophy (MSA). Clarifying the cause changes the trajectory and the response to treatment.
Non-motor symptoms often appear years before movement changes. These include loss of smell, vivid dreams with physical movement during sleep (REM sleep behavior disorder), constipation, lightheadedness on standing, fatigue, anxiety, depression, brain fog, and a softer voice. These symptoms are not incidental. They are part of the same disease process.
Standard neurology centers on confirming the diagnosis and adjusting dopaminergic medication. Integrative care adds a systematic look at the factors affecting daily function and long-term trajectory: sleep architecture, gut health and constipation, insulin resistance, inflammatory load, nutrient gaps, physical conditioning, environmental exposures, and stress. You leave with a prioritized plan across all of these areas, not only a prescription.
The research is compelling. Alpha-synuclein, the protein accumulating in Parkinson's disease, appears to originate in the enteric nervous system of the gut and travel upward through the vagus nerve to the brainstem years before motor symptoms emerge. Constipation is one of the earliest non-motor symptoms. Gut microbiome composition differs measurably between people with Parkinson's disease and healthy controls. Addressing gut health is not alternative medicine. This is evidence-informed neurology.
Pesticide exposure, particularly organophosphates and paraquat, is among the most consistently replicated environmental risk factors for Parkinson's disease. Research links heavy metal exposure, well water contamination, and occupational solvent exposure to elevated risk as well. A thorough exposure history is part of every integrative evaluation.
Yes. Exercise is one of the few interventions with strong evidence for slowing motor decline in Parkinson's disease. High-intensity aerobic exercise, boxing programs, tango and rhythmic movement, and forced-rate cycling have all shown benefit in peer-reviewed trials. Structured physical activity is not optional in an integrative plan. It is a treatment.
Consultations are $99 and paid directly. Integrative and functional medicine components, including targeted lab panels, lifestyle plans, and supplement guidance, are not covered by insurance. Some patients use HSA or FSA accounts. We do not bill insurance for visits, which gives us more time to build a thorough plan with you.
Yes. Dr. Zubkov sees patients via telehealth in Minnesota, Mississippi, Florida, Georgia, Arkansas, and Tennessee. Lab kits ship directly to your home. For patients needing in-person neurologic examination, we work with your local neurology team and bring our integrative plan alongside their findings.
References
- Postuma RB, Berg D, Stern M, et al. "MDS clinical diagnostic criteria for Parkinson's disease." Movement Disorders. 2015;30(12):1591–1601. PubMed
- Braak H, Del Tredici K, Rüb U, et al. "Staging of brain pathology related to sporadic Parkinson's disease." Neurobiology of Aging. 2003;24(2):197–211. PubMed
- Schenkman M, Moore CG, Kohrt WM, et al. "Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease." JAMA Neurology. 2018;75(2):219–226. PubMed
- Athauda D, Foltynie T. "Insulin resistance and Parkinson's disease: A new target for disease modification?" Progress in Neurobiology, 2016, 145-146, 98-120. PubMed
- Tanner CM, Kamel F, Ross GW, et al. "Rotenone, paraquat, and Parkinson's disease." Environmental Health Perspectives. 2011;119(6):866–872. PubMed
Dr. Alexander Y. Zubkov, MD, PhD treats patients across Minnesota and via telehealth in select states. Minnesota communities served include Minneapolis, Saint Paul, Edina, Eden Prairie, Minnetonka, Plymouth, Bloomington, Maple Grove, Eagan, Woodbury, Lakeville, Burnsville, Brooklyn Park, Brooklyn Center, Champlin, Chanhassen, Crystal, Excelsior, Golden Valley, Hopkins, Minnetrista, New Hope, Orono, Robbinsdale, Rogers, St. Louis Park, Victoria, Waconia, Shakopee, Chaska, Coon Rapids, Blaine, St. Cloud, Stillwater, Hudson, and River Falls.
You Deserve More Than a Six-Month Wait
Parkinson's disease and parkinsonism give you years of early-stage time when lifestyle changes, sleep work, and targeted support carry real weight. The window does not stay open forever. A $99 consultation with Dr. Zubkov gives you a neurologist who looks at the whole picture and builds a plan you start this week.
Integrative care provided after medical consultation. Telehealth available in Minnesota and select states.
Email: support@mindbodyneurology.com • Tel: 952-209-6209